Literature DB >> 29055401

How Hepatitis B virus causes cirrhosis and liver cancer.

Yanchao Zhou1, Yulin Wan1, Zi-Wei Ye2, Zhumei He1, Qiuyun Liu3, Yunfan Shi4.   

Abstract

Hepatitis B virus is a major pathogen infecting the liver, causing high morbidity and mortality worldwide, particularly in developing countries. The mechanism underlying progression from infections of Hepatitis B virus to cirrhosis and liver cancer is not fully determined. Here we propose that the HBV X protein traps protons and Cl-, and induces the expression of collagen in the liver, which forms potent hydrogen bonds with trapped protons. The presence of collagen in the liver marks the progression to fibrosis. The X protein and collagen concertedly build up HCl locally, triggering disease advances to liver cancer in some patients with liver cirrhosis. The hypothesis can be tested in Hepatitis B primate model with the administration of calcium and weak acids to ascertain physiological changes and monitor tumorigenesis rate. The experiments will pave the way for better intervention of human infections with Hepatitis B virus.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Basic amino acids; Cirrhosis; Hepatitis B virus X protein; Hydrogen bond donors and acceptors; Liver cancer

Mesh:

Substances:

Year:  2017        PMID: 29055401     DOI: 10.1016/j.mehy.2017.08.005

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  3 in total

1.  Mechanism of HBV-positive liver cancer cell exosomal miR-142-3p by inducing ferroptosis of M1 macrophages to promote liver cancer progression.

Authors:  Zongqiang Hu; Hui Zhang; Wei Liu; Yanfeng Yin; Jie Jiang; Chuntao Yan; Yiting Wang; Li Li
Journal:  Transl Cancer Res       Date:  2022-05       Impact factor: 0.496

2.  Effect of mutations across reverse transcriptase region on HBV replication and progression of liver diseases in Chinese patients.

Authors:  Xiaoqin Lai; Wenfa Chen; Yuzhu Wu; Yali Gao; Yalan Zhang; Xuwei Xu; Ya Fu; Xinwen Wang; Yanbing Yang; Yin Zhang
Journal:  J Clin Lab Anal       Date:  2022-06-03       Impact factor: 3.124

Review 3.  Analysis of Clinical Trials of New Drugs for Liver Diseases in China.

Authors:  Longfei Lin; Hui Li
Journal:  Drug Des Devel Ther       Date:  2021-07-20       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.